Serum immunoglobulin levels during contraceptive use of depot-medroxyprogesterone acetate in Indian women: A preliminary study

Contraception

Volumn 53, Issue 6, 1996, Pages 363-365

  Lali, P ^a   Chandra, L ^a   Gupta, R P ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Contraception; Depot medroxyprogesterone acetate; Progestogen; Serum immunoglobulins; Serum proteins

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEDROXYPROGESTERONE ACETATE; PROTEIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INDIAN; INTRAMUSCULAR DRUG ADMINISTRATION;

ASIA; BIOLOGY; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, PROGESTIN; DEPO-PROVERA; DEVELOPING COUNTRIES; FAMILY PLANNING; HEMATOLOGICAL EFFECTS; HEMIC SYSTEM; IMMUNITY; IMMUNOGLOBULIN ALTERATIONS; IMMUNOLOGICAL EFFECTS; INDIA; MEDROXYPROGESTERONE ACETATE; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; SERUM PROTEIN EFFECTS; SOUTHERN ASIA;

ADULT; ANTIBODY FORMATION; BLOOD PROTEINS; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INDIA; MEDROXYPROGESTERONE 17-ACETATE; PROGESTERONE CONGENERS; SERUM ALBUMIN; TIME FACTORS;

EID: 0029947973     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00086-8     Document Type: Article

References (18)

1. Liskin L, Blackburn R. Hormonal contraception: new long-acting methods. Popul Rep (Series K) 1897;15:57-87.
2. Home CHW, Howie PW, Weir RJ, Gondie RB. Effect of combined oestrogen and progestogen oral contraceptives on serum levels of 2-macroglobulin, transferrin, albumin and IgG. Lancet 1970;i:49-51.
3. Chandra RK. Serum levels of IgG and macroglobulin and incidence of cryo-fibrinogenaemia in women taking oral contraceptive. J Reprod Fertil 1972;28:463-4.
4. Song CS, Meskarz IR, Rifkind AB, Gillette PN, Kappas A. The influence of pregnancy and oral contraceptive steroids on plasma proteins. Am J Obstet Gynecol 1970; 108:227-31.
5. Lanrell CB, Kullander S, Thorell J. Effect of administration of a combined oestrogen-progestin contraceptive on the level of individual plasma proteins. Am J Obstet Gynecol 1967;21:337-43.
6. Bisset LR, Griffin JFT. Humoral immunity in oral contraceptive users. Plasma immunoglobulin levels. Contraception 1988;38:567-72.
7. Gleichmann W, Bachmann GW, Dengler HJ, Dudeck J. Effects of hormonal contraceptives and pregnancy on serum protein pattern. Eur J Clin Pharmacol 1973;5: 218-25.
8. Shabaan MM, Elwan SI, El-Sharkawy MM, Farghaly AS. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver function. Contraception 1984;30;407-12.
9. Broome AWJ, Lamming GE. Studies on the relationship between hormones and uterine injection. II. The role of the antibody system in uterine defects. J Endocrinol 1959;18:229-35.
10. Hulka JF, Mohr K, Lieberman MW. Effect of synthetic progestational agents on allograft rejection and circulation antibody production. Endocrinology 1965;77:897-908.
11. El-Matigoub S, El-Gamal Y, Karim M, Hassan AR, Madha H. Effects of injectable progestogens on the immunologic power of breast milk. Int J Gynecol Obstet 1972;10:48-52.
12. Boyden A, Button E, Germerog D. Precipitin testing with special reference to the measurement of turbidity. J Immunol 1947;57:211.
13. Hellsing K. The effects of different polymers for enhancement of the antigen-antibody reaction as measured with nephelometry in protides of the biological fluids. In: Peeters H, ed. Oxford: Pergamon Press, 1973; 23:579.
14. Kingsley GR. The direct Biuret method for the determination of serum proteins as applied to photoelectric and visual colorimetry. J Lab Clin Med 1942;27:840-5.
15. Pinnel AE, Northam BE. New automated dye-binding method for serum albumin determination with bromocresol purple. Clin Chem 1978;24:80-4.
16. Abdulla KA, Elwan SJ, Salem HS, Shaaban MM. Effect of early postpartum use of the contraceptive implants, Norplant, on serum levels of immunoglobulins of the mothers and their breastfed infants. Contraception 1985; 32:261-6.
17. Singh K, Viegas OAC, Liew D, Singh P, Ratnam SS. The effects of Norplant-2 rods on clinical chemistry in Singaporean acceptors after one year of use: metabolic effects. Contraception 1988;38:453-63.
18. Otolorin EO, Adeyefa I, Konje JC, Ojengbede O, Osotimehin B, Ladipo OA. Plasma immunoglobulin, total protein and albumin levels during Norplant use by Nigerian women. Acta Obstet Gynecol Scand 1993;72: 645-7.